Join
Live feed
·
INSIDERFilingvia Quantisnow
Tourmaline Bio Inc. logo

CEO Kulkarni Sandeep Chidambar bought $71,998 worth of shares (5,221 units at $13.79) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TRML· Tourmaline Bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRML (Tourmaline Bio Inc.) and more on Quantisnow.